TOPAS THERAPEUTICS

topas-therapeutics-logo

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liverโ€™s natural immunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus v... ulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering. Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies. Topasโ€™ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.

#People #Financial #Event #Website #More

TOPAS THERAPEUTICS

Social Links:

Industry:
Advanced Materials Biotechnology Chemical Chemical Engineering

Founded:
2006-01-01

Address:
Hamburg, Hamburg, Germany

Country:
Germany

Website Url:
http://www.topas-therapeutics.com

Total Employee:
51+

Status:
Active

Contact:
+49 40 302089010

Email Addresses:
[email protected]

Total Funding:
58 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Current Employees Featured

klaus-martin_image

Klaus Martin
Klaus Martin Chief Executive Officer @ Topas Therapeutics
Chief Executive Officer
2020-01-01

cristina-min_image

Cristina Min
Cristina Min Chief Medical Officer @ Topas Therapeutics
Chief Medical Officer
2021-09-01

not_available_image

Timm-H. Jessen
Timm-H. Jessen Co-Founder, Board Member and Chief Executive Office @ Topas Therapeutics
Co-Founder, Board Member and Chief Executive Office

not_available_image

Johannes Pohlner
Johannes Pohlner Co-Founder and Chief Operating Officer @ Topas Therapeutics
Co-Founder and Chief Operating Officer

timothy-kneale_image

Timothy Kneale
Timothy Kneale President @ Topas Therapeutics
President

Founder


not_available_image

Johannes Pohlner

klaus-martin_image

Klaus Martin

not_available_image

Timm-H. Jessen

Investors List

evotec-inc_image

Evotec

Evotec investment in Series B - Topas Therapeutics

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series B - Topas Therapeutics

embl-ventures_image

EMBL Ventures

EMBL Ventures investment in Series B - Topas Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Topas Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series B - Topas Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series B - Topas Therapeutics

gimv_image

Gimv

Gimv investment in Series B - Topas Therapeutics

embl-ventures_image

EMBL Ventures

EMBL Ventures investment in Series B - Topas Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Topas Therapeutics

gimv_image

Gimv

Gimv investment in Series B - Topas Therapeutics

Newest Events participated

pre-filled-syringes-east-coast-2017_event_image Participated in Pre-Filled Syringes East Coast 2017 on 2017-04-26 as sponsor

pre-filled-syringes-east-coast-2017_event_image Participated in Pre-Filled Syringes East Coast 2017 on 2017-04-26 as exhibitor

Key Employee Changes

Date New article
2022-02-15 Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer

Official Site Inspections

http://www.topas-therapeutics.com

  • Host name: dd24006.kasserver.com
  • IP address: 85.13.146.149
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Topas Therapeutics"

Topas Therapeutics โ€“ Transforming the field of โ€ฆ

Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 [email protected]See details»

Topas Therapeutics - Crunchbase Company Profile

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet โ€ฆSee details»

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive ...

Oct 19, 2020 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 [email protected]. CONTACT. CONTACT. ... he was Chief โ€ฆSee details»

Topas Therapeutics - Contacts, Employees, Board Members

Organization. Topas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. โ€ฆSee details»

Topas Therapeutics | Boehringer Ingelheim Venture Fund

Topas advances a versatile platform approach to establish immune tolerance in autoimmune and immune-mediated diseases. Topas is a clinical-stage biotech company, which develops a โ€ฆSee details»

Topas Therapeutics (Topas Therapeutics GmbH) - Startbase

Recent mentions of Topas Therapeutics in podcasts & videos: Jobs at Topas Therapeutics: Other Startups nearby. HR Puls. Startup 2012 Hamburg. HR Puls. Cloud based HR Software for โ€ฆSee details»

Topas Therapeutics Company Profile - Office Locations ... - Craft

Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as โ€ฆSee details»

Topas Therapeutics GmbH (TT) - Phoenix

Topas Therapeutics GmbH is a Germany-based and investor-funded biotech company located in Hamburg. Topas is utilizing its cutting-edge technology platform to develop a pipeline of novel therapies to treat autoimmune โ€ฆSee details»

Topas Therapeutics GmbH - VentureRadar

Topas Therapeutics is a clinical-stage biotechnology company with a mission to deliver novel, disease-modifying treatments for autoimmune and inflammatory diseases. At Topas we are โ€ฆSee details»

Topas Therapeutics - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

Evotec spins off auto-immune disease company as 'Topas โ€ฆ

Mar 22, 2016 The new company, Topas Therapeutics GmbH ("Topas"), aims to build a unique pipeline of clinical-stage development projects to treat autoimmune diseases. The proceeds of โ€ฆSee details»

Topas Therapeutics GmbH - Drug pipelines, Patents, Clinical

Explore Topas Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 7 news, and 3 literature, Disease Domain:Immune System Diseases, โ€ฆSee details»

Topas Therapeutics (Topas Therapeutics GmbH) - Startbase

Die neusten Erwähnungen von Topas Therapeutics in Podcasts & Videos: Offene Jobs bei Topas Therapeutics: Weitere Startups in der Nähe von Topas Therapeutics. HR Puls. Startup 2012 โ€ฆSee details»

Topas Therapeutics - Portfolio Company Profile, Executives and โ€ฆ

See Topas Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Topas Therapeutics developed a unique technology for โ€ฆSee details»

Evotec gründet Topas Therapeutics GmbH aus โ€“ ein Unternehmen ...

[email protected] Topas Therapeutics GmbH Falkenried 88, Haus B 20251 Hamburg (Germany) Evotec gründet Topas Therapeutics GmbH aus โ€“ ein Unternehmen spezialisiert โ€ฆSee details»

Topas particle conjugates coupled with tolerogenic peptide โ€ฆ

Topas Therapeutics is focused on developing Topas particle conjugates (TPCs), an antigen coupled nanoparticle platform technology, that target liver sinusoidal endothelial cells to โ€ฆSee details»

Pipeline - Topas Therapeutics

Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 [email protected]See details»

Topas Therapeutics Raises EUR 14 Million to Treat Immunological ...

Mar 22, 2016 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 [email protected]. CONTACT. CONTACT. CONTACT. HOME; โ€ฆSee details»

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief

Hamburg, 19 October 2020: Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction capabilities of the โ€ฆSee details»

Topas claims success in early test of โ€˜immune toleranceโ€™ celiac โ€ฆ

1 day ago Hugo Fry, Topas Therapeutics CEO. May 5, 2025 03:01 AM EDT Updated 06:18 AM. R&D. Ex­clu­sive: Topas claims suc­cess in ear­ly test of 'im­mune tol­er­ance' ther­a­py for celi­ac โ€ฆSee details»